Many of our i-sense team members have received awards or fellowships over the past year - let’s take a closer look at a few of our award updates.
Zyme Biosciences, a team led by Dr Marta Broto Aviles who is an i-sense postdoc in Prof Molly Stevens group at Imperial College London, have made the finals of WE Innovate 2021. The scheme is led by the Imperial Enterprise Lab and provides a platform to showcase the incredible progress being made in women’s entrepreneurship at Imperial – with winning teams receiving a part of a 30K prize fund for their ideas.
New research from the i-sense group at UCL, published in Biosensors and Bioelectronics, addresses the urgent need for more accurate rapid diagnostics for COVID-19 by developing an isothermal test that simultaneously detects two gene targets.
World-renowned sexual health experts are behind a new NHS digital revolution for people with sexually transmitted infections (STIs) using a new automated online consultation giving patients 24-hour access to medical care.
A team of scientists, led by Glasgow Caledonian University Prof of HIV and Sexual Health, and i-sense member, Prof Claudia Estcourt, have launched an ambitious five-year research project to develop a new NHS digital platform to improve care for people with STIs.
The quantum sensing abilities of nanodiamonds can be used to improve the sensitivity of paper-based diagnostic tests, potentially allowing for earlier detection of diseases such as HIV, according to a study led by researchers in the i-sense McKendry group at UCL.
Antibiotic resistence is a growing global concern and major threat to human health.
The standard method used to detect resistance in bacteria, known as phenotypic antibiotic sensitivity testing, monitors bacterial growth over about 12 – 24 hours and is therefore a slow process. New rapid methods for antibiotic sensitivity testing are urgently needed to improve antibiotic stewardship.
UCL has launched Virus Watch, inviting 50,000 households to take part in one of the largest and most comprehensive studies of COVID-19 in the UK.
The study, which will require participants to complete regular online symptom surveys, seeks to better understand community spread of the virus.